The organizers explain the aim of the PrEP in Europe summit “is to articulate how we, as members of the affected communities and their allies, want to be able to benefit from PrEP.
Rise in drug-fuelled parties is behind spike in new HIV cases across Europe but gay men involved are often too closeted to reach
In many European countries, people who identify as transgender must have a mental health diagnosis to get their official records changed.
All of this if of course only a small glimpse of what is happening.
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
Results from a large-scale European study among serodiscordant gay couples show that adherence to effective treatment prevents transmission of HIV
Ultra-right activists broke windows and reportedly used tear gas on police outside a hotel where the European Lesbian Conference will take place. Despite threats, conference organizers said they would not be intimidated.
Monthly injections of long-acting cabotegravir (ViiV Healthcare) and rilpivirine (Edurant, Janssen) can suppress HIV as well as daily oral antiretroviral treatment, according to results from the ATLAS (NCT02951052) and FLAIR
ILGA-Europe and 21 other civil society organisations and unions today launch #ElectNoHate, our joint call for EU elections campaigning free from hate speech and divisive rhetoric, which legitimise hateful actions and pose a threat to human rights.
When taken daily, emtricitabine/tenofovir disoproxil fumarate (F/TDF) for HIV pre-exposure prophylaxis (PrEP) has a high success rate of preventing HIV infection.
Today, on the 14th of February 2019, the European Parliament has adopted a landmark Resolution on the Rights of Intersex People.
Report ‘Funding for LGBTI Activism in Europe and Central Asia launched’ by ILGA-Europe and the Global Philanthropy Project.